MedPath

GERAP's Epidemiological Survey on Perioperative Hypersensitivity Reactions

Recruiting
Conditions
Hypersensitivity, Drug
Registration Number
NCT04654923
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Perioperative hypersensitivity reactions are still associated with significant morbidity and mortality despite early recognition and use of epinephrine. The epidemiology of these reactions evolves over time and changes with clinical practice. The main objective is to study the epidemiology of these reactions over a 10-year period, including patient phenotype, reaction phenotype and outcome of the allergic work-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
3000
Inclusion Criteria
  • Minor and major subject
  • Subject having experienced a perioperative hypersensitivity reaction between January the 1st 2017 and December the 31st 2027.
  • Referred for an allegro-anesthetic workup
  • Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.
Exclusion Criteria
  • Subject having expressed opposition to participating in the study
  • Inability to provide the subject with research information
  • Subject under guardianship or guardianship
  • Subject under safeguard of justice

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Retrospective analysis of incidence of all perioperative hypersensitivity reactions referred in an allegro-anestheticOutcome is analysed every 2 years over a 10 years period
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service d'anesthésie-réanimation - CHU de Strasbourg - France

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath